CAMRF:OTC-Camurus AB (publ) (USD)

COMMON STOCK | |

Last Closing

USD 56.65

Change

0.00 (0.00)%

Market Cap

USD 0.45B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-03 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
PSZKF Powszechna Kasa Oszczednosci B..

N/A

USD 13.13B
SHZHY Shenzhou International Group H..

N/A

USD 12.03B
ELPQF El Puerto de Liverpool S.A.B. ..

N/A

USD 10.80B
PSHZF Pershing Square Holdings Ltd

N/A

USD 10.25B
IDKOF Idemitsu Kosan Co.Ltd

N/A

USD 9.59B
EFGSF Eiffage SA

N/A

USD 8.15B
SKSUF Sekisui Chemical Co. Ltd

N/A

USD 7.67B
AZRGF Azrieli Group Ltd

N/A

USD 7.63B
RUMOF Rumo S.A

N/A

USD 7.02B
DFKCY Daifuku Co. Ltd

N/A

USD 6.64B

ETFs Containing CAMRF

ZJO:CA 4.39 % 0.60 %

N/A

N/A
GASX 4.34 % 1.01 %

N/A

N/A
GASL 1.55 % 1.19 %

N/A

N/A
IWN iShares Russell 2000 Valu.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 159.74% N/A N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 159.74% N/A N/A 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 31.76% N/A N/A 72% C
Dividend Return 31.76% N/A N/A 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 43.10% N/A N/A 55% F
Risk Adjusted Return 73.69% N/A N/A 95% A
Market Capitalization 0.45B N/A N/A 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.